​

DarioHealth (DRIO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DRIO Stock Forecast

DarioHealth (DRIO) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $10.75, with a high of $14.00 and a low of $7.50. This represents a 1435.71% increase from the last price of $0.70.

- $3 $6 $9 $12 $15 High: $14 Avg: $10.75 Low: $7.5 Last Closed Price: $0.7

DRIO Stock Rating

DarioHealth stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 8 Strong Sell Sell Hold Buy Strong Buy

DRIO Price Target Upside V Benchmarks

TypeNameUpside
StockDarioHealth1435.71%
SectorHealthcare Stocks 23.68%
IndustryDiagnostics & Research Stocks22.21%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.70$0.70$0.70
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25-31--4
May, 25-21--3
Apr, 25-21--3
Mar, 25-21--3
Feb, 25-21--3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 16, 2022Industrial Alliance Securities$7.50$5.1844.79%971.43%
Aug 18, 2022Cowen & Co.$14.00$5.49155.01%1900.00%
May 16, 2022Cowen & Co.$18.00$6.33184.36%2471.43%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 19, 2025Litchfield HillsBuyinitialise
Jun 14, 2024Cowen & Co.BuyBuyhold
Nov 16, 2022Alliance Global PartnersBuyBuyhold
Aug 18, 2022Aegis CapitalBuyBuyhold
Aug 18, 2022Cowen & Co.OutperformOutperformhold
May 16, 2022Aegis CapitalBuyBuyhold
May 16, 2022Cowen & Co.OutperformOutperformhold
May 13, 2022Alliance Global PartnersBuyupgrade

Financial Forecast

EPS Forecast

$-6 $-5 $-4 $-3 $-2 $-1 $0 $1 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-4.86$-4.63$-2.63$-1.93$0.61---
Avg Forecast$-5.13$-4.72$-2.93$-1.54$-1.12$-1.01$-0.86$-0.63
High Forecast$-4.97$-4.57$-2.83$-1.46$-1.07$-0.96$-0.60$-0.60
Low Forecast$-5.31$-4.89$-3.00$-1.64$-1.20$-1.08$-1.11$-0.67
Surprise %-5.26%-1.91%-10.24%25.32%-154.46%---

Revenue Forecast

$5M $14M $23M $32M $41M $50M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$7.58M$20.51M$27.66M$20.35M$27.04M---
Avg Forecast$7.60M$20.61M$27.59M$20.50M$26.81M$35.63M$41.35M$47.14M
High Forecast$7.82M$21.19M$28.09M$21.54M$28.16M$37.43M$43.44M$49.52M
Low Forecast$7.42M$20.12M$26.84M$19.73M$25.80M$34.29M$39.79M$45.36M
Surprise %-0.37%-0.49%0.23%-0.75%0.86%---

Net Income Forecast

$-200M $-150M $-100M $-50M $0 $50M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-28.99M$-76.76M$-62.19M$-59.43M$40.98M---
Avg Forecast$-145.41M$-133.88M$-83.24M$-44.05M$-32.30M$-28.99M$-24.26M$-18.02M
High Forecast$-140.92M$-129.74M$-80.31M$-41.55M$-30.31M$-27.34M$-16.90M$-17.00M
Low Forecast$-150.69M$-138.74M$-85.20M$-46.56M$-33.96M$-30.64M$-31.61M$-19.05M
Surprise %-80.06%-42.66%-25.29%34.89%-226.88%---

DRIO Forecast FAQ

Is DarioHealth stock a buy?

DarioHealth stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that DarioHealth is a favorable investment for most analysts.

What is DarioHealth's price target?

DarioHealth's price target, set by 8 Wall Street analysts, averages $10.75 over the next 12 months. The price target range spans from $7.5 at the low end to $14 at the high end, suggesting a potential 1435.71% change from the previous closing price of $0.7.

How does DarioHealth stock forecast compare to its benchmarks?

DarioHealth's stock forecast shows a 1435.71% upside, outperforming the average forecast for the healthcare stocks sector (23.68%) and outperforming the diagnostics & research stocks industry (22.21%).

What is the breakdown of analyst ratings for DarioHealth over the past three months?

  • June 2025: 0% Strong Buy, 75.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 66.67% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 0% Strong Buy, 66.67% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.

What is DarioHealth’s EPS forecast?

DarioHealth's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.01, marking a -265.57% decrease from the reported $0.61 in 2024. Estimates for the following years are $-0.86 in 2026, and $-0.63 in 2027.

What is DarioHealth’s revenue forecast?

DarioHealth's average annual revenue forecast for its fiscal year ending in December 2025 is $35.63M, reflecting a 31.78% increase from the reported $27.04M in 2024. The forecast for 2026 is $41.35M, and $47.14M for 2027.

What is DarioHealth’s net income forecast?

DarioHealth's net income forecast for the fiscal year ending in December 2025 stands at $-28.988M, representing a -170.73% decrease from the reported $40.98M in 2024. Projections indicate $-24.258M in 2026, and $-18.022M in 2027.